Neonatal Outcomes after Use of Buprenorphine during Pregnancy

被引:4
|
作者
Krans, Elizabeth E. [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA 15260 USA
[2] Magee Womens Res Inst, Pittsburgh, PA 15261 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2022年 / 387卷 / 22期
关键词
ABSTINENCE SYNDROME; METHADONE;
D O I
10.1056/NEJMe2212967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The opioid crisis in the United States has had profound effects on pregnant persons and their children. Over the past decade, the rate of opioid-related diagnoses during pregnancy has increased across nearly all states and demographic groups,(1) and overdose is now a leading cause of pregnancy-related deaths.(2) In pregnancy, the use of medications such as methadone and buprenorphine for opioid use disorder reduces the risks of overdose and preterm birth and is the recommended evidence-based treatment approach for pregnant persons with the disorder.(3,4) For more than 30 years, methadone was the medication that was predominantly used to treat opioid use . . .
引用
收藏
页码:2085 / 2086
页数:2
相关论文
共 50 条
  • [1] Effects of Methadone and Buprenorphine Use During Pregnancy on Neonatal and Maternal Outcomes
    Moustafa, Ahmed S. Z.
    Kumar, Navin
    Masten, Megan
    Bruder, Adrienne
    Rocha, Frederico
    Adekola, Henry
    [J]. OBSTETRICS AND GYNECOLOGY, 2019, 133 : 118S - 119S
  • [2] Clearance of buprenorphine during pregnancy and neonatal outcomes
    Jessica L. Coker
    Shona L. Ray-Griffith
    Cody McLeod
    Xiaotong Han
    Michael Mancino
    Gregory L. Kearns
    Zachary N. Stowe
    [J]. Archives of Women's Mental Health, 2021, 24 : 933 - 939
  • [3] Clearance of buprenorphine during pregnancy and neonatal outcomes
    Coker, Jessica L.
    Ray-Griffith, Shona L.
    McLeod, Cody
    Han, Xiaotong
    Mancino, Michael
    Kearns, Gregory L.
    Stowe, Zachary N.
    [J]. ARCHIVES OF WOMENS MENTAL HEALTH, 2021, 24 (06) : 933 - 939
  • [4] Neonatal outcomes and their relationship to maternal buprenorphine dose during pregnancy
    Jones, Hendree E.
    Dengler, Erin
    Garrison, Anna
    O'Grady, Kevin E.
    Seashore, Carl
    Horton, Evette
    Andringa, Kim
    Jansson, Lauren M.
    Thorp, John
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2014, 134 : 414 - 417
  • [5] Does the management of buprenorphine during pregnancy affect neonatal outcomes?
    Walker, K.
    Shah, D.
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 : S251 - S252
  • [6] Buprenorphine during Pregnancy: Clearance, Fetal Exposure and Neonatal Outcomes
    Coker, Jessica
    McLeod, Cody
    Narayanan, Sreedharan
    David, Thomas
    Ritchie, James
    Mancino, Michael
    Stowe, Zachary
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S422 - S423
  • [7] Reducing buprenorphine dose during pregnancy leads to improved neonatal outcomes
    Miller, Lauren A.
    Link, Heather
    Carey, Katelyn
    Seligman, Neil
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (01) : S141 - S142
  • [8] Neonatal and maternal outcomes following maternal use of buprenorphine or methadone during pregnancy: findings of a retrospective audit
    Blandthorn, Julie
    Forster, Della A.
    Love, Veronica
    [J]. WOMEN AND BIRTH, 2011, 24 (01) : 32 - 39
  • [9] Use of buprenorphine during pregnancy
    Reisinger, M
    [J]. BUPRENORPHINE - A SUBSTITUTION AGENT FOR THE TREATMENT OF OPIOID ADDICTION: A UK PERSPECTIVE, 1997, 19 (02): : 43 - 45
  • [10] A prospective study on buprenorphine use during pregnancy:: effects on maternal and neonatal outcome
    Kahila, Hanna
    Saisto, Terhi
    Kivitie-Kallio, Satu
    Haukkamaa, Maija
    Halmesmaki, Erja
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2007, 86 (02) : 185 - 190